Genascence Announces First Close in Series a Financing Led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, today announced it has completed the first closing in a Series A financing led by Pacira BioSciences, Inc., totaling $10.5 million. As part of the financing, UF Innovate's Jackson Streeter, joins Genascence's board of directors.
UF Innovate | Accelerate Welcomes John Mayfield to Its Advisory Board
UF Innovate | Accelerate is honored to welcome John D. Mayfield, Ph.D., vice president of corporate and business development at EQRx, to its advisory board.
Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board
UF Innovate | The Hub resident client Oxidien Pharmaceuticals announced two additions to its newly organized Strategic Advisory Board (SAB).
UF Innovate | Sid Martin Biotech Announces New Board of Advisors
UF Innovate | Sid Martin Biotech is pleased to announce a new board of advisors to provide mentorship for client companies at... Read More
